Precision proton beams target rare bone tumors
NCT ID NCT01449149
Summary
This study tested whether proton radiation therapy could safely treat two rare types of bone cancer called chordomas and chondrosarcomas. Researchers wanted to see if this more targeted radiation approach could control these difficult tumors while causing fewer side effects like severe fatigue compared to standard radiation. The trial involved 54 adults with these cancers in the skull or spine who hadn't spread to other body parts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHONDROSARCOMAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.